KDM6B and rheumatoid arthritis: Wu et al. [191] found that in synovioblasts of RA patients, cystathionine-gamma-lyase inhibited the progression of joint inflammation by reducing the expression of KDM6B, suppressing the transcription of TLR2 and some inflammatory factors including TNF-α and IL-6.